Smithfield Foods is caught in an unusual split: short interest has roughly doubled over six weeks while options positioning has turned the most call-heavy it has been all year, a disagreement in the market worth watching ahead of the next earnings print on 29 October.
The short side has been moving fast. Short interest has risen 54% over the past month to reach 1.5% of the free float, around 5.9 million shares. That is still a low absolute level, but the pace matters: nearly all of that build came in a single step around 22 September, when borrowed shares jumped from roughly 4.8 million to 5.9 million in a day. Despite that acceleration, the borrow market shows no signs of stress. Availability is generous at 740%, meaning there are more than seven shares available to lend for every one currently borrowed. Borrowing costs remain negligible at 0.48%, and the lending pool holds 27.6 million shares. The short build is real, but it is not a crowded or costly trade.
The call against the bears is being made in the options market. The put/call ratio has dropped to 0.50, well below its 20-day average of 0.68 and 1.5 standard deviations below that mean. That is the most call-skewed reading of the past year, with the 52-week low sitting at 0.17 and the high at 1.75. Investors have been rotating away from downside protection steadily since late August, when the PCR topped 0.98. The shift is striking because it is happening into a stock that has lost 13% over the past month and closed at $19.01, down 2.8% on the week.
The Street is broadly still constructive, though targets have drifted lower. Barclays maintained its Overweight rating this month but cut its target from $31 to $29, the second trim since August, when it came down from $32. B of A Securities holds a Buy rating with a $32 target, last adjusted in July. The most recent action came this week: Stephens & Co. initiated coverage with an Equal-Weight rating and a $22 target, the most cautious stance of the bunch and closest to where the stock actually trades. The consensus mean target of $26.75 implies roughly 41% upside from current prices, though the stock has to cover a lot of ground to get there. Valuation is undemanding: the PE multiple is 8.7, down 0.2 points over the past month, and EV/EBITDA sits at 5.8. The EV/EBIT rank scores in the 92nd percentile of the universe, meaning the stock looks cheap on an operating earnings basis relative to almost all peers. EPS momentum, however, ranks in single digits over both 30 and 90-day windows, a persistent drag on the combined score.
Ownership is heavily concentrated: WH Group Limited holds 87% of shares as last disclosed in November 2025, leaving a thin tradeable float. The 102 institutional holders on record hold collectively modest stakes. Among those, AQR Capital Management added roughly 3 million shares in the quarter to June, and Goldman Sachs reported adding 1.85 million shares over the same period. Those are notable additions relative to the available float. Retail attention has also climbed, with the Wikipedia/ORTEX page-view signal running at a z-score of 2.9 against the prior 90 days, suggesting the stock is drawing more eyes than usual.
The earnings reaction record offers a cautionary data point. The most recent print, on 11 August, produced a 7% one-day drop and an 8% five-day loss. The print before that was essentially flat on day one but closed 2% lower by day five. With results due 29 October, the combination of a fast-building short interest, call-heavy options positioning, and a stock sitting 13% below where it was a month ago sets up a narrow but charged window: the next number to watch is whether the pace of the short build continues into earnings, or whether the call buyers prove prescient first.
See the live data behind this article on ORTEX.
Open SFD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.